Biorasi is a contract research organization (CRO) widely recognized for delivering success in complex clinical trials. This is possible through TALOS™, an innovative operating model that unifies systems and teams with a powerful project

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

MEDX HEALTH ANNOUNCES ADDITION OF TWO NEW SCREENING SERVICES LOCATIONS IN OTTAWA

MedX Health Corp | January 28, 2022

news image

Teledermatology company MedX Health Corp. is pleased to announce the launch of MedX Screening Services to be offered at two locations in Ottawa, Canada – ProMed Pharmacy, an independent, pharmacist owned pharmacy enterprise, and Dura Wellness Clinic a retail, clinical focused esthetic services group. Both locations will now offer MedX scanning services and accept walk-in patients. "This represents the next step in our business plan for North Americ...

Read More

Pharma Tech

ADVAXIS AND AYALA PHARMACEUTICALS ENTER INTO MERGER AGREEMENT

Advaxis and Ayala Pharmaceuticals | October 20, 2022

news image

Ayala Pharmaceuticals, Inc. a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers and Advaxis, Inc. a biotechnology company devoted to the discovery, development and commercialization of immunotherapies based on a technology which uses engineered Listeria monocytogenes, today announced that they have entered into a definitive merger agreement. The merger would result in a combined com...

Read More

Business Insights, PHARMACY MARKET

MINDMED ANNOUNCES EXCLUSIVE LICENSE AGREEMENT WITH CATALENT FOR ITS PATENTED ZYDIS® FAST-DISSOLVE TECHNOLOGY FOR USE WITH MM-120

Businesswire | August 07, 2023

news image

Mind Medicine Inc a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it has entered into a license agreement with Catalent, a leader in enabling the development and supply of better treatments for patients worldwide, to access Catalent’s proprietary Zydis® orally disintegrating tablet (ODT) technology. Under the terms of the licensing agreement, Catalent has granted MindMed access to its ...

Read More

Pharma Tech

VALGENESIS AND PHARMENG TECHNOLOGY PARTNER TO MODERNIZE AND DIGITIZE VALIDATION AND COMPLIANCE FOR GLOBAL PHARMA, BIOTECH, MEDICAL DEVICE

PRNewswire | June 07, 2023

news image

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and PharmEng Technology, a global ISO-certified consulting firm focused on life sciences, have partnered to provide a range of regulatory intelligence, GxP compliance, and digitized validation solutions for pharmaceutical, biotechnology, medical device, and nutraceutical companies across the globe. PharmEng Technology has staff all over the world serving companies of all sizes, prov...

Read More
news image

Business Insights

MEDX HEALTH ANNOUNCES ADDITION OF TWO NEW SCREENING SERVICES LOCATIONS IN OTTAWA

MedX Health Corp | January 28, 2022

Teledermatology company MedX Health Corp. is pleased to announce the launch of MedX Screening Services to be offered at two locations in Ottawa, Canada – ProMed Pharmacy, an independent, pharmacist owned pharmacy enterprise, and Dura Wellness Clinic a retail, clinical focused esthetic services group. Both locations will now offer MedX scanning services and accept walk-in patients. "This represents the next step in our business plan for North Americ...

Read More
news image

Pharma Tech

ADVAXIS AND AYALA PHARMACEUTICALS ENTER INTO MERGER AGREEMENT

Advaxis and Ayala Pharmaceuticals | October 20, 2022

Ayala Pharmaceuticals, Inc. a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers and Advaxis, Inc. a biotechnology company devoted to the discovery, development and commercialization of immunotherapies based on a technology which uses engineered Listeria monocytogenes, today announced that they have entered into a definitive merger agreement. The merger would result in a combined com...

Read More
news image

Business Insights, PHARMACY MARKET

MINDMED ANNOUNCES EXCLUSIVE LICENSE AGREEMENT WITH CATALENT FOR ITS PATENTED ZYDIS® FAST-DISSOLVE TECHNOLOGY FOR USE WITH MM-120

Businesswire | August 07, 2023

Mind Medicine Inc a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it has entered into a license agreement with Catalent, a leader in enabling the development and supply of better treatments for patients worldwide, to access Catalent’s proprietary Zydis® orally disintegrating tablet (ODT) technology. Under the terms of the licensing agreement, Catalent has granted MindMed access to its ...

Read More
news image

Pharma Tech

VALGENESIS AND PHARMENG TECHNOLOGY PARTNER TO MODERNIZE AND DIGITIZE VALIDATION AND COMPLIANCE FOR GLOBAL PHARMA, BIOTECH, MEDICAL DEVICE

PRNewswire | June 07, 2023

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and PharmEng Technology, a global ISO-certified consulting firm focused on life sciences, have partnered to provide a range of regulatory intelligence, GxP compliance, and digitized validation solutions for pharmaceutical, biotechnology, medical device, and nutraceutical companies across the globe. PharmEng Technology has staff all over the world serving companies of all sizes, prov...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us